In a landmark decision that is tipped to normalise the use of medicinal cannabis, the United Nations has voted to remove cannabis from being a Schedule IV drug, sending the ASX cannabis sector upward in a regulatory move that will encourage individual nations to follow suit. The UN drugs treaty was first introduced in 1961
Read More
Australian cannabis company Little Green Pharma (ASX: LGP) has reached a major commercial achievement in their long-term strategy having been granted a manufacturing licence for cannabis products at their newly commissioned facility in Western Australia. “The grant represents the culmination of LGP’s long-term regulatory strategy and is a clear watershed moment for the Company. The
Read More
Having been subject to a harsh reality check over the last year or so, the ASX listed cannabis sector is applauding the local medicine regulator’s endorsement of the weed as an effective therapy that should be more freely available to the ailing masses. But the path to the pharmacy is likely to be harder than
Read More
Pharmaceuticals company AusCann (ASX: AC8) is set to progress to the next stage of clinical trials having successfully completed their first round on Neuvis, their cannabinoid-based capsule developed to treat nerve pain – an area of medicine that is inadequately met. Estimated to affect 7-10% of Australians, nerve pain is caused by damage to the
Read More
Despite a gloomy day on the ASX yesterday, Australian cannabis companies ended it very well upon news of the Therapeutic Goods Association (TGA) announcing they will amend legislation that will open a clear path for Australians to purchase cannabidiol (CBD) products without a prescription. The notice of interim decision was released confirming that the TGA
Read More
Global pharmaceutics and cannabis healthcare company Althea Group (ASX: AGH) has harnessed the power of telehealth through COVID-19, almost doubling web-based enquiries for their MyAccess Clinics in the UK where patients can seek medicinal cannabis treatment pathways. With the England being one of the harder nations hit by COVID-19, Althea accelerated telehealth offerings for its
Read More